{"id":"W2616754233","doi":"10.2147/ott.s136484","title":"The HIV protease inhibitor, nelfinavir, as a novel therapeutic approach for the treatment of refractory pediatric leukemia","year":2017,"lang":"en","type":"article","venue":"OncoTargets and Therapy","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"ca_institutions":"Alberta Children's Hospital; University of Calgary","funders":"Alberta Children's Hospital Foundation; Children's Hospital Foundation","keywords":"Nelfinavir; Protease inhibitor (pharmacology); Refractory (planetary science); Medicine; Leukemia; Human immunodeficiency virus (HIV); Protease; Pharmacology; Virology; Immunology; Chemistry; Antiretroviral therapy; Biology; Enzyme; Viral load","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002266767,0.0002824571,0.0002942507,0.0004345632,0.0001444774,0.0004303579,0.0002799885,0.0002393879,0.00077172],"category_scores_gemma":[0.0001044927,0.0000703225,0.0002498254,0.0002984048,0.0001857328,0.0002865993,0.0001973968,0.0005308563,0.0001743234],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002722545,"about_ca_system_score_gemma":0.0002651848,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002372873,"about_ca_topic_score_gemma":0.001086471,"domain_scores_codex":[0.9999379,0.00001526206,0.000006068223,0.00001125573,0.00001822433,0.00001131213],"domain_scores_gemma":[0.9999639,0.000006019423,0.00001291289,0.000002901236,0.000005579813,0.000008669233],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.001709878,0.0007545972,0.003487294,0.002025296,0.000147217,0.001815335,0.0001594846,0.001283161,0.1961035,0.003159546,0.005521512,0.7838332],"study_design_scores_gemma":[0.003045877,0.01893816,0.0324015,0.001582839,0.001010706,0.0377839,0.0003182391,0.007416473,0.2405994,0.00343313,0.6533422,0.0001275404],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.294755,0.6851922,0.005590786,0.002261005,0.0004547065,0.0001812731,0.0004109753,0.0002012622,0.01095271],"genre_scores_gemma":[0.6696892,0.3151426,0.009473163,0.001096105,0.0003664909,0.0001158947,0.0006251223,0.00002256799,0.003468772],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.00077172,"threshold_uncertainty_score":0.002581716,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03497320728294501,"score_gpt":0.2994211456358922,"score_spread":0.2644479383529472,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}